Literature DB >> 21297754

Controversy in cancer of the breast.

E B Fish.   

Abstract

Cancer of the breast is a capricious disease. Until we know the etiology and can accurately appraise its extent we cannot give accurate prognosis and our therapy is often palliative. There are still controversies over the incidence and whether any true change has been made in mortality from the disease. The place of xeromammography in detecting cancer of the breast is still unsettled. When there are so many unknowns it is not remarkable that the best treatment is so controversial. Each form of therapy has advantages and disadvantages; at present we are unable to predict with accuracy which patient will benefit most from which regimen. We need adequate numbers of patients in properly controlled studies to draw conclusions from reports on the course and therapy of such a variable disease.

Entities:  

Year:  1979        PMID: 21297754      PMCID: PMC2383156     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  8 in total

1.  Progress in the treatment of breast cancer. Invited commentary.

Authors:  B Fisher
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

2.  Mammography. An epidemiologist's critique.

Authors:  A B Miller
Journal:  Can Med Assoc J       Date:  1979-06-09       Impact factor: 8.262

3.  Increasing incidence and decreasing mortality rates for breast cancer.

Authors:  S J Cutler; B Christine; T H Barclay
Journal:  Cancer       Date:  1971-12       Impact factor: 6.860

4.  An assessment of mammography.

Authors:  M E Forbes; H Banting
Journal:  J Can Assoc Radiol       Date:  1967-12

5.  Mammography: a surgeon's experience.

Authors:  J E Devitt
Journal:  Can Med Assoc J       Date:  1979-06-09       Impact factor: 8.262

6.  Results of conservative treatment of breast cancer at ten and 15 years.

Authors:  G Crile
Journal:  Ann Surg       Date:  1975-01       Impact factor: 12.969

7.  Cancer of the breast: Its outcome as measured by the rate of dying and causes of death.

Authors:  C B Mueller; W Jeffries
Journal:  Ann Surg       Date:  1975-09       Impact factor: 12.969

8.  The curability of breast cancer.

Authors:  D Brinkley; J L Haybrittle
Journal:  Lancet       Date:  1975-07-19       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.